![Andrew L. Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew L. Finn
Keine laufenden Positionen mehr
Profil
Andrew L.
Finn is the founder of Arius Pharmaceuticals, Inc. (founded in 2003) and enVision Sciences, Inc. (founded in 1996).
At Arius Pharmaceuticals, Inc., he held the title of EVP-Clinical Development & Regulatory Affairs.
At enVision Sciences, Inc., he held the title of Chief Executive Officer from 1996 to 1999.
Dr. Finn's former jobs include Executive Vice President-Product Development at BioDelivery Sciences International, Inc. (2004-2015) and POZEN, Inc. (2000-2003), and Vice President-US Clinical Research at Solvay Pharmaceuticals, Inc. (1991-1996).
Dr. Finn received a doctorate degree from the University of Michigan and an undergraduate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Andrew L. Finn
| Unternehmen | Position | Ende |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Corporate Officer/Principal | 31.12.2015 |
| POZEN INC. | Corporate Officer/Principal | 01.01.2003 |
enVision Sciences, Inc.
 enVision Sciences, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Gründer | 01.01.1999 |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 |
Arius Pharmaceuticals, Inc.
 Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for surgical and oncology patients | Gründer | 04.08.2009 |
Ausbildung von Andrew L. Finn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Arius Pharmaceuticals, Inc.
Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for surgical and oncology patients | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enVision Sciences, Inc.
enVision Sciences, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
